Skip to content

RNA

Avidity Biosciences, Inc.

NASDAQ · Healthcare · Biotechnology · US

$8.95
−6.38%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 12, 2026
EPS estimate
-$0.87
Revenue estimate
$15.0M

Latest reported

Last report date
Aug 13, 2026
EPS actual
-$1.18
EPS estimate
-$1.42
Revenue actual
$3.0M
Revenue estimate
$666.7K

Track record

Trailing twelve quarters

EPS beats (12Q)
5
EPS misses (12Q)
7
EPS in line (12Q)
0
Avg surprise (4Q)
-1.3%
Revenue beats (12Q)
7
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 13, 2026-$1.42-$1.18Beat 16.90%$3.0M
May 14, 2026-$1.05-$0.97Beat 7.62%$19.6M
Aug 7, 2025-$0.95-$1.21Miss -27.37%$3.8M
May 8, 2025-$0.88-$0.90Miss -2.27%$1.6M
Feb 27, 2025-$0.76-$0.80Miss -5.26%$3.0M
Nov 7, 2024-$0.71-$0.65Beat 8.45%$2.3M
Aug 9, 2024-$0.76-$0.65Beat 14.47%$2.0M
May 9, 2024-$0.81-$0.79Beat 2.47%$3.5M
Feb 28, 2024-$0.54-$0.79Miss -46.30%$2.2M
Feb 28, 2023-$0.84-$0.88Miss -4.76%$2.8M
Mar 1, 2022-$0.73-$0.82Miss -12.33%$1.9M
May 12, 2021-$0.52-$0.64Miss -23.08%$2.7M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026